Covidien Ltd. (NYSE: COV; BSX: COV) announced today that its Board
of Directors has declared a quarterly cash dividend of $0.16 per
common share. The dividend is payable on November 9, 2007 to
shareholders of record on October 9, 2007.
"This declaration, our first dividend as a public company, is an
important milestone for the Company and its investors," said President
and Chief Executive Officer Richard J. Meelia.
ABOUT COVIDIEN LTD.
Covidien is a leading global healthcare products company that
creates innovative medical solutions for better patient outcomes and
delivers value through clinical leadership and excellence. Covidien
manufactures, distributes and services a diverse range of
industry-leading product lines, including Surgical Devices,
Energy-based Devices, Respiratory and Monitoring Solutions, Patient
Care and Safety Products, Imaging Solutions, Pharmaceutical Products,
Medical Supplies and Retail Products. With 2006 revenue of nearly $10
billion, Covidien has more than 43,000 employees worldwide in 57
countries, and its products are sold in over 130 countries. For
additional information, please visit our website, www.covidien.com.
